Eslicarbazepine study for adults with partial-onset seizures
Part of Brain & nervous system clinical trials.
This study tests a medication called eslicarbazepine for adults who have partial-onset seizures. It may help people who are newly diagnosed or who have not had good results with two common seizure medicines, carbamazepine or oxcarbazepine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with partial-onset seizures (a type of seizure that starts in one part of the brain)
- You are newly diagnosed and have not yet started any seizure medicine, OR you have taken carbamazepine or oxcarbazepine and it hasn't worked or you couldn't tolerate it
- You are not allergic to eslicarbazepine
- You are not pregnant or breastfeeding
- You or your legal representative can give informed consent, or if you cannot, a healthcare professional authorizes your participation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests XEN1101 compared with a placebo (inactive pill) in people with focal-onset seizures that haven’t been fully controlled despite trying at least two anti-seizure medicines. If you qualify, you may help researchers see whether the study drug reduces seizure frequency and improves control.
This trial looks at ways to diagnose and treat focal epilepsy that isn't controlled by medications. It includes patients with or without a visible brain lesion on imaging.
This study tests a liquid form of the seizure medicine zonisamide in children aged 1 month to 17 years. It aims to see how the medicine works in the body and whether it is safe and well-tolerated for controlling partial-onset seizures.
This trial tests a new medication, CB03-154, to see if it is safe and can reduce seizures in adults with focal epilepsy. You may be able to join if you have had focal epilepsy for at least 2 years and are on a stable dose of 1 to 3 anti-seizure medications.
This study tests a new device that sends mild electrical pulses to the brain to reduce seizures in people whose seizures are not controlled by medication. It may help if you have at least four seizures a month despite taking anti-seizure drugs.
This Phase 2 trial tests SPN-817 in adults whose seizures are still not well controlled despite trying multiple seizure medicines. It targets people with a specific type of brain finding called focal cortical dysplasia and looks at safety/tolerability and seizure outcomes over several weeks.
Hear when a new Focal Onset Seizures trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.